Making Money Trading Stem Cell Companies

In 2008, most of the money made in the stock market was from the Energy sector. Solar, oil, and coal stocks all soared to record highs. However, nothing in life lasts forever and the energy bull market was no exception. Although I rarely agree with "Mad Money" host Jim Cramer, I do share his feeling that "there is always a bull market somewhere". In 2009, it appears the new bull market is in Biotechnology. More specifically, Stem Cell companies will lead the pack thanks to a philosophical change from government due to Barack Obama's new presidency.

Stem cell companies over the years have been over-hyped, yet under funded. Obama appears to be adamant in significantly increasing the funding in this area. The combination of new money entering the sector, along with renewed interest, and a bottoming market, makes for the perfect storm in stock trading.

The event that began to put teeth in the speculation of this Biotech surge was when the FDA approved Geron Corp's application for the world's first human clinical trial for embryonic stem cell-based therapy on 1/23/09. Since this epic announcement, the flood gates have opened on most publicly traded stem cell companies. It's barely been a week since the announcement and many of these companies have already seen incomprehensible appreciations in there stock price. I don't profess to be a wall street tycoon or Biotech expert. However, being an Mechanical Engineering graduate from Clemson University in 1998 and long time stock trader, I certainly understand patterns and technical reversals. Believe me when I say the rise has just only begun.

In this blog, I will chronicle the share price movement of many of these stem cell companies, identify catalyst for the week, and provide notable trends and events for specific stocks in the sector. In essence, this will be a daily one stop shop for you to see which stocks are ripe for trading. See below for the stocks I'll be following:

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA)
Aastrom Biosciences (ASTM)
Celgene Corp (CELG)
Geron Corp. (GERN)
ThermoGenesis (KOOL)
StemCell, Inc. (STEM)

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.PK)
Athersys, Inc.(ATHX)
Brainstorm Cell Therapeutics Inc.(BCLI.OB)
Bioheart Inc.(BHRT)
Cord Blood America Inc.(CBAI.OB)
Cyro-Cell International (CCEL.OB)
Neuralstem (CUR)
International Stem Cell Corp.(ISCO.OB)
LifeStem International (LSTM)
MultiCell Technologies (MCET.OB)
Osiris Therapeutics (OSIR)
Pluristem Therapeutics (PSTI)
Stem Cell Therapy Intl (SCII)
Stem Cell Innovations (SCLL.PK)
Vitro Diagnostics (VODG.OB)

Let's all make some money!